PARP Inhibition for Gliomas (PI-4G or π4g)

Clinical trial NCT05297864 · TERMINATED

Trial details

NCT number: NCT05297864
Sponsor: University of Oklahoma
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Recurrent Glioblastoma Recurrent Astrocytoma Recurrent Oligodendroglioma Recurrent Glioma

Start date: 2022-06-09
Primary completion: 2023-11-14
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.